ILLUMINA, INC. for ILLUMINA, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 21, 2024 | $260,000 | Replaced |
| 3rd Quarter - Amendment | Dec 12, 2024 | $280,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2369: VALID Act of 2023; provisions related to the the Food and Drug Administration's Laboratory Developed Tests (LDT) Rule and regulation of diagnostics and lab developed tests H.R. 2407: Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act; provisions related to coverage of Multi-Cancer Early Detection (MCED) tests General discussions related to the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLAS MAGALLANES | — |
Defense DEF
H.R. 8333: BIOSECURE Act; provisions related to genomics issues pertaining to national security
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLAS MAGALLANES | — |
Budget/Appropriations BUD
H.R. 9747: Continuing Appropriations and Extensions Act, 2025; provisions related to government funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| NICOLAS MAGALLANES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.